Cancer-Associated Mesothelial Cells Drive Immune Escape and Therapy Resistance in Ovarian Cancer
Maeva Y. Chauvin, Julien Roche-Prellezo, Virginie Lafont, Henri‐Alexandre Michaud, Estelle Tromelin, Robin Michel, Clara Freixinos, Marie-Charlotte Meinsohn, Pierre‐Emmanuel Colombo, Nathalie Bonnefoy, Laurent Gros, David Pépin
This study identifies cancer-associated mesothelial cells (CAMCs) as drivers of immune escape and therapy resistance in ovarian cancer by altering immune cell infiltration and function.
Journal for ImmunoTherapy of Cancer · Jul 1, 2026Peer-reviewedCancer Biology